Company Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.
It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery.
It primarily serves cataract doctors.
The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017.
RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Country | United States |
IPO Date | Jul 30, 2021 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 374 |
CEO | Dr. Ronald M. Kurtz M.D. |
Contact Details
Address: 100 Columbia Aliso Viejo, California United States | |
Website | https://www.rxsight.com |
Stock Details
Ticker Symbol | RXST |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001111485 |
CUSIP Number | 78349D107 |
ISIN Number | US78349D1072 |
Employer ID | 94-3268801 |
SIC Code | 3851 |
Key Executives
Name | Position |
---|---|
Dr. Ronald M. Kurtz M.D. | President, Chief Executive Officer & Director |
Dr. Ilya Goldshleger Ph.D. | Co-President & Chief Operating Officer |
Matt Haller Ph.D. | Chief Technology Officer |
Shelley B. Thunen | Co-President & Chief Financial Officer |
Caroline Vaughn | Vice President of Human Resources |
Eric J. Weinberg | Co-President & Chief Commercial Officer |
Oliver Moravcevic | Vice President of Investor Relations |
Rebecca Williston | Vice President of Accounting & Finance |
Roy Freeman | Senior Vice President of Marketing & Professional Relations |
Steve Everly | Senior Vice President of Sales of North America |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 03, 2024 | 4 | Filing |
Nov 26, 2024 | 4 | Filing |
Nov 26, 2024 | 4 | Filing |
Nov 18, 2024 | 4 | Filing |
Nov 14, 2024 | 4 | Filing |
Nov 14, 2024 | 4 | Filing |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 08, 2024 | 4 | Filing |